Rigel Pharmaceuticals Inc (RIGL.OQ)
4.06USD
19 Apr 2018
$0.00 (+0.00%)
$4.06
--
--
--
244,137
587,474
$4.71
$2.15
Latest Key Developments (Source: Significant Developments)
Rigel Announces Pricing Of Public Offering Of Common Stock
April 19 (Reuters) - Rigel Pharmaceuticals Inc
Rigel Intends To Offer & Sell Up To 15 Mln Shares Of Its Stock In Underwritten Public Offering
April 18 (Reuters) - Rigel Pharmaceuticals Inc
Rigel Pharmaceuticals NDA For Tavalisse Approved By FDA
April 17 (Reuters) - U.S. Food And Drug Administration::RIGEL PHARMACEUTICALS NDA FOR TAVALISSE APPROVED BY FDA. Full Article
Rigel Makes Statement Regarding Website Error
April 12 (Reuters) - Rigel Pharmaceuticals Inc
Rigel Pharma Q4 Loss Per Share $0.18
March 6 (Reuters) - Rigel Pharmaceuticals Inc
Rigel to Provide Business Review and Updated Phase 2 Results for Fostamatinib
Jan 4 (Reuters) - Rigel Pharmaceuticals Inc
Rigel Announces Resignation Of Ryan Maynard, Executive Vice President And CFO Effective December 31, 2017
Dec 15 (Reuters) - Rigel Pharmaceuticals Inc
Rigel announces Q3 loss of $0.14 per share
Nov 7 (Reuters) - Rigel Pharmaceuticals Inc
Rigel announces pricing of public offering of common stock
Oct 4 (Reuters) - Rigel Pharmaceuticals Inc
Rigel Pharmaceuticals q2 loss per share $0.15
Rigel Pharmaceuticals Inc
BRIEF-Rigel Announces Pricing Of Public Offering Of Common Stock
* PUBLIC OFFERING OF 16,000,000 SHARES OF ITS COMMON STOCK, OFFERED AT A PRICE OF $3.90 PER SHARE TO PUBLIC Source text for Eikon: Further company coverage: